Trial · NCT04558554
Results by group16
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 16 of 16
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| PrEP Initiation | Study 1a: Pharmacy-based PrEP Delivery Pilot (13 Months) | 287 | Participants | ||
| PrEP Initiation | Study 2: Pharmacy-based PrEP Delivery Pilot Extension (6 Months) | 661 | Participants | ||
| PrEP Retention | Study 1a: Pharmacy-based PrEP Delivery (13 Months) | Any PrEP continuation | 153 | Participants | |
| PrEP Retention | Study 1b: Pharmacy-based PrEP Refill (12 Months) | Any PrEP continuation | 41 | Participants | |
| PrEP Retention | Study 2: Pharmacy-based PrEP Delivery Pilot Extension (6 Months) | Any PrEP continuation | 476 | Participants | |
| PrEP Retention | Study 1a: Pharmacy-based PrEP Delivery (13 Months) | No PrEP continuation | 134 | Participants | |
| PrEP Retention | Study 1b: Pharmacy-based PrEP Refill (12 Months) | No PrEP continuation | 65 | Participants | |
| PrEP Retention | Study 2: Pharmacy-based PrEP Delivery Pilot Extension (6 Months) | No PrEP continuation | 185 | Participants | |
| PEP Initiation | Study 2: Pharmacy-based PrEP Delivery Pilot Extension (6 Months) | 162 | Participants | ||
| Selection of Pharmacy-based PrEP Refills | Study 1b: Pharmacy-based PrEP Delivery Refill (12 Months) | 3 | Participants | ||
| PrEP Adherence | Study 1a: Pharmacy-based PrEP Delivery (13 Months) | 16 | Participants | ||
| PrEP Adherence | Study 2: Pharmacy-based PrEP Delivery Pilot Extension (6 Months) | 16 | Participants | ||
| STI Testing Uptake | Study 2: Pharmacy-based PrEP Delivery Pilot Extension (6 Months) | 53 | Participants | ||
| Transition From PEP to PrEP | Study 2: Pharmacy-based PrEP Delivery Pilot Extension (6 Months) | 30 | Participants | ||
| PrEP Initiation Among STI Testing Clients | Study 2: Pharmacy-based PrEP Delivery Pilot Extension (6 Months) | 45 | Participants | ||
| Selection of Option to Self-administer HIV Risk Assessment Screening Tool | Study 2: Pharmacy-based PrEP Delivery Pilot Extension (6 Months) | 151 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04558554/results